Impact of l-carnitine on contrast induced nephropathy

Not Applicable

• Conditions: ischemic heart disease.; Myocardial ischemia followed by decreased oxygen to the myocardium; I20-I25

• Registration Number: IRCT201212178698N5
• Lead Sponsor: Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 320

Inclusion Criteria

Patients with ischemic heart disease that have more than 50 percent occlusion in angiography findings and candidates for elective Pecrcutaneous Coronary Intevention.Exclusion criteria: cardiogenic shock;ST Elevation Myocardial Infarction;pregnant and lactating womens;patients under 18 years;immunologic or hematologic disorders;current infection;chronic kidney disease;serum creatinine above 2.5 mg/dl;hypothyroidism;epilepsy or convulsion;chronic liver disease;cancer

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
(Neutrophil gelatinase-associated lipocalin (NGAL. Timepoint: baseline and 12 hour after. Method of measurement: Elisa kit.;(Glomerular Filtration Rate (GFR. Timepoint: baseline and 48 hour after. Method of measurement: determination of serum creatinine by chromatography.

Secondary Outcome Measures

Name	Time	Method
Renal function. Timepoint: 1 month later. Method of measurement: evaluation of patient condition such as death and renal function.